Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity
Authors:
- 1 December 1999
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 53 (10) , 455-461
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restrictionThe American Journal of Clinical Nutrition, 1996
- Evidence for a relationship between plasminogen activator inhibitor-1 and gamma glutamyl transferaseThrombosis Research, 1996
- Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variablesJournal Of Hypertension, 1995
- Non-esterified fatty acids are related with hypofibrinolysis in type 2 diabetes mellitusFibrinolysis, 1994
- Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic menDiabetologia, 1993
- Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.Journal of Clinical Investigation, 1993
- Fibrin and Its Derivatives in the Normal and Diseased Vessel WallAnnals of the New York Academy of Sciences, 1992
- Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarctionThrombosis Research, 1987
- Obesity, Atherosclerosis, and Coronary Artery DiseaseAnnals of Internal Medicine, 1985
- Assessment of Insulin Sensitivityin Vivo*Endocrine Reviews, 1985